BMY vs MRCY · P/E 17, rev $24.46B vs rev $983.6M
Bristol-Myers Squibb Company (BMY) versus Mercury Systems Inc (MRCY) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Mercury Systems Inc (MRCY) is a aerospace & defense company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MRCY revenue for 2026-07-03 was $983.6M. Net income was -$29.7M. Revenue was up 7.9% from 2025-06-27 to 2026-07-03. MRCY currently screens at market cap $6.96B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MRCY currently screens at market cap $6.96B.
Not investment advice. Open the BMY and MRCY stock pages for the full models.
Not investment advice.